SARS-CoV-2

SARS-CoV-2

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • COVID-19: Will vaccinated people in South Africa need booster shots?

    The two vaccines used in South Africa’s vaccination programme, those from Johnson & Johnson and Pfizer/BioNTech, have both been shown to be highly effective against COVID-19, particularly in preventing hospitalisation and death. But protection may wane over time and new variants may or may not render these vaccines less effective. Adele Baleta unpacks what we…

    ·

  • How can we improve ventilation to prevent COVID-19 and TB?

    Ventilation plays an important role in preventing the transmission of airborne diseases but currently, ventilation standards for buildings are focused on preventing odours in spaces, instead of preventing disease transmission. Elri Voigt spoke to two experts about the role of ventilation in the transmission of airborne diseases such as tuberculosis and COVID-19 and what can…

    ·

  • Trial of potentially variant-proof vaccine ongoing in Western Cape

    An experimental COVID-19 vaccine currently in Phase I trials being run by the University of Cape Town has a unique design that might allow it to offer better protection against current and future variants of the SARS-CoV-2 virus. Elri Voigt provides an update on the trial and unpacks the science behind this vaccine candidate.

    ·

  • World TB Day – let’s seize this moment to change the status quo

    Like with SARS-CoV2, we need to rapidly implement and scale-up effective tuberculosis (TB) prevention interventions, while remaining adaptive to prevailing needs across the country. If we choose to pursue this more deliberate approach to TB prevention in South Africa, World TB Day will no longer be an admission of insufficient progress, but a celebration of…

    ·

  • 30% increase in maternal deaths during COVID-19 lockdown reported

    Reproductive health experts say South Africa recorded a 30% increase in maternal deaths during lockdown compared to the same period in 2019. Suicide, a previously unrecognised cause of maternal mortality in the country, also increased and some experts believe the stressors of the COVID-19 pandemic played a role. Tiyese Jeranji reports.

    ·

  • COVID-19 in kids: What have we learnt one year later?

    It has been over a year since the world saw the first confirmed case of COVID-19, yet the science behind the virus’ physical impact on children remains relatively unclear. Kathryn Cleary spoke to two experts in paediatrics and immunology to get an update on what we have learnt so far.

    ·

  • After a rough 17 years, is Biovac finally on track?

    South Africa has struggled to secure adequate stock of urgently needed COVID-19 vaccines. This has raised questions about the state of the country’s local vaccine manufacturing capacity and why, after almost two decades of government support, South Africa’s partially state-owned vaccine manufacturer Biovac is not better positioned to respond to the pandemic. Catherine Tomlinson investigates.

    ·

  • Where are we in the race for a HIV vaccine?

    While progress in the race for effective COVID-19 vaccines has been rapid and impressive, an effective HIV vaccine remains elusive. As part of Spotlight’s World AIDS Day 2020 coverage, Kathryn Cleary asks two of South Africa’s top vaccine researchers to update us on where we are in the race for an HIV vaccine.

    ·